Cingulate Inc (CING)

NASDAQ
Currency in USD
4.760
-0.220(-4.42%)
Closed
CING Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
4.7604.950
52 wk Range
1.80058.320
Key Statistics
Edit
Prev. Close
4.98
Open
4.87
Day's Range
4.76-4.95
52 wk Range
1.8-58.32
Volume
70.39K
Average Vol. (3m)
167.51K
1-Year Change
-91.22%
Book Value / Share
5.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CING Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
39.250
Upside
+724.58%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Cingulate Inc Company Profile

Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

Compare CING to Peers and Sector

Metrics to compare
CING
Peers
Sector
Relationship
P/E Ratio
−0.9x−1.8x−0.6x
PEG Ratio
−0.01−0.010.00
Price / Book
1.3x0.6x2.6x
Price / LTM Sales
-7.7x3.1x
Upside (Analyst Target)
-174.3%53.6%
Fair Value Upside
Unlock10.5%8.0%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 39.250

(+724.58% Upside)

Earnings

Latest Release
Mar 08, 2024
EPS / Forecast
-- / -5.55
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

4.6700
SNTI
+11.46%
3.300
ZEO
+41.03%
1.280
TVGN
+5.79%
2.84
RZLV
-5.65%
0.569
TRUG
0.00%

FAQ

What Is the Cingulate (CING) Stock Price Today?

The Cingulate stock price today is 4.76

What Stock Exchange Does Cingulate Trade On?

Cingulate is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Cingulate?

The stock symbol for Cingulate is "CING."

What Is the Cingulate Market Cap?

As of today, Cingulate market cap is 15.29M.

What is Cingulate Earnings Per Share?

The Cingulate EPS is -22.31.

From a Technical Analysis Perspective, Is CING a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.